Press Release Out Today from the Offices of Thought Leader Select
December 23, 2010 (CHAPEL HILL, NC)—Dr. Maher “Max” Noureddine, a noted Parkinson’s disease researcher and chief scientific officer at North Carolina-based research firm Thought Leader Select, is leaving the company to launch the Institute for Advanced Career Development (IACD) on January 3, 2011.
The institute will offer an array of programs for medical professionals seeking to advance their academic careers in their respective medical fields. Programs on offer will include a physician-centric curriculum called MedMentors, courses for nurses called RNMentors, and courses for pharmacists and veterinarians called PharMentors and VetMentors, respectively.
In addition to the programs centered on leadership in allied health professions, Dr. Noureddine will lead development courses for legal professionals interested in understanding the science of DNA-based evidence. Dr. Noureddine is trained in human molecular genetics with years of laboratory research experience at top institutions such as UNC-Chapel Hill, Duke Medical Center, and The National Institutes of Health.
“I am excited to take all of my scientific training and combine it with my experience in working directly with leading academic medical specialists from across the globe,” stated Noureddine. “While I am sad to be leaving Thought Leader Select, I am doing so with the company’s complete endorsement—they really believe in what I’m doing to advance scientific careers for better healthcare delivery. In addition, I also believe that we can make a significant improvement in the medicolegal arena when it comes to interpreting and evaluating the results of genetic testing in the courts.”
During his four years at Thought Leader Select, Dr. Noureddine pioneered service innovations for the company, including Thought Leader Index, the company’s web-based physician portal for scenario planning, and Thought Leader Emerge, a database where the company tracks developments and achievements in the careers of emerging young thought leaders in a host of disease states.
“There is no doubt that Maher will be missed,” stated Paul Meade, Thought Leader Select’s president and founder. “He’s been a great leader in this company, and he leaves behind a legacy of encouraging and leading the development of new ideas that serve the needs of our clients and help to advance the careers of many young physicians and other medical professionals. The Institute for Advanced Career Development will be a place where physicians wishing to advance their academic careers can gain insight into the optimal pathway to achieving success.”
Dr. Noureddine can be reached by telephone at (919) 349-6990 and by email at mnoureddine@theiacd.com.
About Thought Leader Select
Thought Leader Select serves the biopharmaceutical and healthcare industries, as well as the medical community at large by assessing medical experts (known as “thought leaders” and “key opinion leaders”) within a host of therapeutic areas such as diabetes, oncology, and neurology.
Over two dozen of the top 50 global biopharmaceutical and healthcare companies count on our expertise when seeking to launch new medications for better public health, ensuring that they are collaborating with the right medical professionals for the right reasons—their skills and experiences.
Media Contact:
Brian Castle
Director of Global Marketing and Client Relations
919-360-9690
bcastle@thoughtleaderselect.com
